Centessa Historical Income Statement
| CNTA Stock | USD 15.75 0.09 0.57% |
Historical analysis of Centessa Pharmaceuticals income statement accounts such as Depreciation And Amortization of 981.9 K, Interest Expense of 12 M or Selling General Administrative of 33.9 M can show how well Centessa Pharmaceuticals PLC performed in making a profits. Evaluating Centessa Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Centessa Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Centessa Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Centessa Pharmaceuticals is a good buy for the upcoming year.
Centessa |
About Centessa Income Statement Analysis
Centessa Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Centessa Pharmaceuticals shareholders. The income statement also shows Centessa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Centessa Pharmaceuticals Income Statement Chart
Add Fundamental
Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Centessa Pharmaceuticals. It is also known as Centessa Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Centessa Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Centessa Pharmaceuticals PLC is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Centessa Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Centessa Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At present, Centessa Pharmaceuticals' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Depreciation And Amortization is expected to grow to about 981.9 K, whereas Net Interest Income is forecasted to decline to (1.8 M).
| 2023 | 2024 | 2025 (projected) | Depreciation And Amortization | 813.1K | 935.1K | 981.9K | Interest Income | 10.5M | 12.0M | 12.6M |
Centessa Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Centessa Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Centessa Pharmaceuticals income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 6K | 34.0K | 130.9K | 813.1K | 935.1K | 981.9K | |
| Interest Expense | 378K | 2.5M | 7.0M | 9.9M | 11.4M | 12.0M | |
| Selling General Administrative | 1.1M | 43.0M | 55.2M | 53.7M | 61.8M | 33.9M | |
| Other Operating Expenses | 10.4M | 139.3M | 210.3M | 178.1M | 204.9M | 119.5M | |
| Operating Income | (10.4M) | (139.3M) | (212.3M) | (171.3M) | (154.2M) | (161.9M) | |
| Ebit | (10.4M) | (379.2M) | (212.4M) | (166.9M) | (150.2M) | (157.7M) | |
| Research Development | 9.3M | 96.3M | 155.1M | 124.4M | 143.1M | 85.7M | |
| Ebitda | (10.4M) | (379.2M) | (212.3M) | (166.1M) | (149.5M) | (156.9M) | |
| Total Operating Expenses | 10.4M | 139.3M | 210.3M | 178.1M | 204.9M | 119.5M | |
| Income Before Tax | (10.7M) | (381.7M) | (217.0M) | (176.1M) | (158.5M) | (166.5M) | |
| Total Other Income Expense Net | (223K) | (6.9M) | (4.7M) | (4.9M) | (4.4M) | (4.6M) | |
| Net Income | (11.0M) | (381.9M) | (216.2M) | (151.1M) | (136.0M) | (142.8M) | |
| Income Tax Expense | 378K | 114.0K | (747K) | (25.1M) | (22.6M) | (21.4M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Centessa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Centessa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Centessa Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Centessa Pharmaceuticals Plc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.